Website profile

Pharmadispatch

News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals

  • 35articles · 30d
  • 11+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 91%with images
  • 132avg words
articles per day
Categories
  • Medical 30
  • Health & Wellness 25
  • Health 23
  • Business & Industrial 10
  • Economy, Business & Finance 5
  • Finance & Business 4
  • Science & Technology 4
  • Human Interest 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

PharmaDispatch
pharmadispatch.com > news > australia-secures-sovereign-viral-vector-manufacturing-as-vvmf-wins-tga-licence

Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence

4+ day, 7+ hour ago   (159+ words) PharmaDispatch Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence A Sydney company has become the first in Australia to earn a manufacturing licence for viral vectors, a milestone it says strengthens the nation's capacity to make advanced…...

PharmaDispatch
pharmadispatch.com > news > melbourne-oncologist-takes-the-reins-at-australias-private-cancer-physicians-body

Melbourne oncologist takes the reins at Australia's private cancer physicians body

4+ day, 7+ hour ago   (154+ words) PharmaDispatch Melbourne oncologist takes the reins at Australia's private cancer physicians body After twelve years steering the Private Cancer Physicians of Australia through some of the most consequential fights in Australian cancer policy, Christopher Steer has handed the presidency to…...

PharmaDispatch
pharmadispatch.com > news > noxopharm-pushes-sofra-platform-towards-cancer-proof-of-concept

Noxopharm pushes Sofra platform towards cancer proof of concept

2+ week, 4+ day ago   (133+ words) PharmaDispatch Noxopharm pushes Sofra platform towards cancer proof of concept Noxopharm says new laboratory findings strengthen the case for using its Sofra technology to help the immune system recognise cancer cells after treatments such as chemotherapy or radiotherapy kill them....

PharmaDispatch
pharmadispatch.com > news > personalised-mrna-cancer-therapy-clears-phase-3-milestone-in-resected-melanoma

Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma - BioPharmaDispatch

3+ week, 3+ day ago   (135+ words) Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma PharmaDispatch Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma Professor Georgina Long, the study's principal investigator and medical director of Melanoma Institute Australia, said the findings could signal…...

PharmaDispatch
pharmadispatch.com > news > new-zealand-researchers-honoured-for-work-tackling-superbugs-and-blood-cancer

New Zealand researchers honoured for work tackling superbugs and blood cancer

3+ week, 4+ day ago   (138+ words) PharmaDispatch New Zealand researchers honoured for work tackling superbugs and blood cancer Two New Zealand scientists working at very different points of the medicines-development pipeline will be recognised tonight at Medicines New Zealand’s 2026 Value of Medicines Awards. … Opportunity #1 - biosimilar policy…...